跳转至内容
Merck

RIP

Sigma-Aldrich

Imprint® RNA免疫沉淀试剂盒

High-capacity Protein A magnetic beads for successful RNA Immunoprecipitation,suitable for use with mRNA and microRNA

别名:

Magnetic Bead RNA Immunoprecipitation, RNA Immunopreciptation, mRNA Immunopreciptation, microRNA Immunoprecipitation

登录查看公司和协议定价


About This Item

分類程式碼代碼:
41116158
NACRES:
NA.54

相关类别

一般說明

RNA免疫沉淀(RIP)是研究核糖核蛋白(RNP)复合物中RNA结合蛋白(RBP)及其RNA靶点的强大方法。抗特定RBP的抗体被用于共沉淀RNP,即RBP及其RNA伴侣。然后,可以通过下一代测序鉴定RNA或通过RT-PCR检测特定RNA。
当与合适的抗体联用时,Imprint RNA免疫沉淀试剂盒可提供RIP实验成功所需的所有试剂。该试剂盒包括两种裂解缓冲液:一种较为温和,与RNP结合不紧密;另一种则很苛刻,可与RNP密切结合。其中随附蛋白A磁珠,用于收集免疫沉淀物,方便洗涤。该试剂盒还包括用于阴性对照RIP的兔和小鼠IgG,以及一种兔抗鼠的桥接抗体,用于将小鼠单克隆一抗有效结合至磁珠上的蛋白A;其中还含有蛋白酶和核糖核酸酶抑制剂,可保护RIP实验过程中RNP不被降解。

详细了解 该产品并查看应用数据

應用

Imprint® RNA免疫沉淀试剂盒已可用于:
  • 适用于下游应用
  • 从个体靶标表征到全基因组图谱分析技术
  • 信号转导途径的表征
  • 验证ChIp-chIP和ChIP-seq数据

特點和優勢

  • 更高结合能力的Xtra蛋白A磁珠
  • 细胞裂解和免疫沉淀的分步实验方案
  • 包含RNA酶抑制剂和无RNA酶试剂,以保持RNA的完整性
  • 内附阴性对照,且包含抗体

法律資訊

Imprint is a registered trademark of Merck KGaA, Darmstadt, Germany

试剂盒组分也可单独购买

产品编号
说明
化学品安全说明书

  • I5381IgG from mouse serum, reagent grade, ≥95% (SDS-PAGE), lyophilized powder化学品安全说明书

  • I5006IgG from rabbit serum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder化学品安全说明书

  • M7023Anti-Mouse IgG (whole molecule) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution化学品安全说明书

  • P8340Protease Inhibitor Cocktail, for use with mammalian cell and tissue extracts, DMSO solution化学品安全说明书

  • R1158Ribonuclease Inhibitor, recombinant, expressed in E. coli, 20-40 units/μL化学品安全说明书

象形圖

FlameExclamation mark

訊號詞

Warning

危險分類

Aquatic Chronic 3 - Eye Irrit. 2 - Flam. Liq. 3 - Skin Irrit. 2

儲存類別代碼

3 - Flammable liquids

水污染物質分類(WGK)

WGK 3

閃點(°F)

100.4 °F

閃點(°C)

38 °C


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Zhi-Jun Zhu et al.
Biochemical and biophysical research communications, 497(4), 971-977 (2018-02-11)
Long non-coding RNAs are critically involved in oncogenesis in various cancer types. Here we reported a novel lncRNA signature correlated with progression of non-small cell lung cancer (NSCLC). In particular, we identified elevated expression of terminal differentiation-induced noncoding RNA (TINCR)
Huijuan Xiao et al.
Cell & bioscience, 8, 23-23 (2018-03-29)
The acquisition of drug resistance has been considered as a main obstacle for cancer chemotherapy. Tumor protein 53 target gene 1 (TP53TG1), a p53-induced lncRNA, plays a vital role in the progression of human cancers. However, little is known about
Yu-Yuan Qian et al.
Oncotarget, 8(64), 107859-107869 (2018-01-04)
Long non-coding RNA PTENP1, the pseudogene of PTEN tumor suppressor, was previously reported to be a tumour suppressor in some cancer types. However, the precise effects mediated by PTENP1 transcripts within intricate regulatory networks involving molecular interactions with PTEN and
Nicola Amodio et al.
Leukemia (2018-03-01)
The biological role and therapeutic potential of long non-coding RNAs (lncRNAs) in multiple myeloma (MM) are still to be investigated. Here, we studied the functional significance and the druggability of the oncogenic lncRNA MALAT1 in MM. Targeting MALAT1 by novel
Lin Cao et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 93, 570-579 (2017-07-08)
Non-small cell lung cancer (NSCLC), known as the most common type of lung cancer, has caused great economic losses and brought the patients with NSCLC great suffering. The NSCLC chemo-resistance to cisplatin (DDP) -based chemotherapy remains a huge challenge. The

商品

Sigma’s Imprint RNA Immunoprecipitation Kit was used to copurify human argonaute 2 (Ago2)-associated RNAs from HeLa cells. MicroRNAs reverse transcribed and quantitating using Mysticq reagents.

实验方案

Procedure and protocol for Anti Ago-RNA Immunoprecipitation from mammalian cells using the RIP kit

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门